✦ LIBER ✦

Isotretinoin and Risk of Inflammatory Bowel Disease: A French Nationwide Study

✍ Scribed by Racine, Antoine; Cuerq, Anne; Bijon, Anne; Ricordeau, Philippe; Weill, Alain; Allemand, Hubert; Chosidow, Olivier; Boutron-Ruault, Marie-Christine; Carbonnel, Franck

Book ID: 121652703
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 140 KB
Volume: 109
Category: Article
ISSN: 0002-9270
DOI: 10.1038/ajg.2014.8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isotretinoin and Risk for Inflammatory B

Isotretinoin and Risk for Inflammatory Bowel Disease

✍ Etminan, Mahyar; Bird, Steven T.; Delaney, Joseph A.; Bressler, Brian; Brophy, J 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 175 KB

Isotretinoin Use and the Risk of Inflamm

Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study

✍ Alhusayen, Raed O; Juurlink, David N; Mamdani, Muhammad M; Morrow, Richard L; Sh 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Of Blemishes and Bowels: Isotretinoin an

Of Blemishes and Bowels: Isotretinoin and Inflammatory Bowel Disease

✍ Justin L. Sewell; Uma Mahadevan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB

400 Isotretinoin use and Risk of Inflamm

400 Isotretinoin use and Risk of Inflammatory Bowel Disease: A Case Control Study From the French National Health Insurance System

✍ Antoine Racine; Anne Cuerq; Anne Bijon; Philippe Ricordeau; Hubert Allemand; Mar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

P419 Isotretinoin use and risk of inflam

P419 Isotretinoin use and risk of inflammatory bowel disease: A case control study from the French national health insurance system

✍ A. Racine; A. Cuerq; A. Bijon; P. Ricordeau; H. Allemand; M.C. Boutron-Ruault; F 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 63 KB

Risk of malignant lymphoma in patients w

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose